Deutsche Bank’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-487,360
| Closed | -$7.67M | – | 3745 |
|
|
2024
Q1 | $7.67M | Buy |
487,360
+1,174
| +0.2% | +$18.1K | ﹤0.01% | 1116 |
|
|
2023
Q4 | $7.84M | Buy |
486,186
+231,515
| +91% | +$2.95M | ﹤0.01% | 1081 |
|
|
2023
Q3 | $3.24M | Buy |
254,671
+68,435
| +37% | +$944K | ﹤0.01% | 1180 |
|
|
2023
Q2 | $2.62M | Buy |
186,236
+5,964
| +3% | +$85.3K | ﹤0.01% | 1497 |
|
|
2023
Q1 | $2.79M | Buy |
180,272
+158,544
| +730% | +$2.65M | ﹤0.01% | 1504 |
|
|
2022
Q4 | $356K | Buy |
21,728
+1,324
| +6% | +$21.5K | ﹤0.01% | 2634 |
|
|
2022
Q3 | $377K | Sell |
20,404
-8,559
| -30% | -$134K | ﹤0.01% | 2554 |
|
|
2022
Q2 | $381K | Sell |
28,963
-67,665
| -70% | -$747K | ﹤0.01% | 2766 |
|
|
2022
Q1 | $896K | Buy |
96,628
+61,172
| +173% | +$520K | ﹤0.01% | 2419 |
|
|
2021
Q4 | $347K | Sell |
35,456
-114,317
| -76% | -$2.15M | ﹤0.01% | 3056 |
|
|
2021
Q3 | $5.09M | Sell |
149,773
-1,447
| -1% | -$46.2K | ﹤0.01% | 1491 |
|
|
2021
Q2 | $5.54M | Sell |
151,220
-28,094
| -16% | -$1.09M | ﹤0.01% | 1458 |
|
|
2021
Q1 | $8.04M | Sell |
179,314
-2,019
| -1% | -$94K | ﹤0.01% | 1305 |
|
|
2020
Q4 | $10.3M | Sell |
181,333
-67,167
| -27% | -$3.98M | 0.01% | 1021 |
|
|
2020
Q3 | $12.7M | Buy |
248,500
+70,429
| +40% | +$3.45M | 0.01% | 870 |
|
|
2020
Q2 | $10.6M | Buy |
178,071
+41,667
| +31% | +$2.23M | 0.01% | 953 |
|
|
2020
Q1 | $5.62M | Sell |
136,404
-28,027
| -17% | -$1.56M | 0.01% | 1191 |
|
|
2019
Q4 | $10.2M | Sell |
164,431
-67,947
| -29% | -$3.23M | 0.01% | 1071 |
|
|
2019
Q3 | $7.88M | Buy |
232,378
+133,749
| +136% | +$3.96M | 0.01% | 1179 |
|
|
2019
Q2 | $2.22M | Buy |
98,629
+1,531
| +2% | +$35.8K | ﹤0.01% | 2328 |
|
|
2019
Q1 | $2.25M | Buy |
97,098
+87
| +0.1% | +$2.28K | ﹤0.01% | 2406 |
|
|
2018
Q4 | $2.04M | Sell |
97,011
-45,745
| -32% | -$1.12M | ﹤0.01% | 2391 |
|
|
2018
Q3 | $5.53M | Buy |
142,756
+27,232
| +24% | +$1.01M | ﹤0.01% | 2113 |
|
|
2018
Q2 | $4.55M | Buy |
115,524
+104,908
| +988% | +$3.09M | ﹤0.01% | 2371 |
|
|
2018
Q1 | $212K | Sell |
10,616
-7,485
| -41% | -$190K | ﹤0.01% | 4167 |
|
|
2017
Q4 | $410K | Buy |
+18,101
| New | +$354K | ﹤0.01% | 3712 |
|
Other funds holding DCPH
Deutsche Bank's DCPH Position: Q2 2024 in Review
Deutsche Bank sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 487,360 shares — an estimated $7.67M sold.
Deutsche Bank first reported a position in DCPH in Q4 2017 and held it in 26 quarters. The position peaked at $12.7M in Q3 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Deutsche Bank reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Deutsche Bank sold 487,360 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $7.67M.
- Deutsche Bank first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 26 quarters.
- Deutsche Bank's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $12.7M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.